104846-62-0Relevant articles and documents
Development of an improved process for doxercalciferol via a continuous photochemical reaction
Anderson, Bruce G.,Bauta, William E.,Cantrell, William R.
, p. 967 - 975 (2012)
Doxercalciferol (1α-hydroxyvitamin D2) is a commercially approved vitamin D derivative used to treat chronic kidney disease (CKD) patients whose kidneys cannot metabolically introduce a hydroxyl group at C1. A new process for the production of doxercalcif
Improved and efficient synthesis of Maxacalcitol
Feng, Shi,Cui, Li-Fei,Wei, He-Geng,Zheng, Guo-Jun,Wang, Ya-Ping,Wang, Xiang-Jing,Zhang, Ji,Xiang, Wen-Sheng
, p. 771 - 774 (2014/06/09)
Maxacalcitol, the 22-oxa-derivative of 1α, 25-dihydroxyvitamin D 3, has been used as an antihyperparathyroidism and antipsoriatic drug. In this paper, an alternative synthetic route has been developed using commercially available vitamin D
SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
-
Page/Page column 13; 37, (2008/12/07)
The invention provides a method of producing 20-methyl vitamin D3 compounds of formula (I). The method includes hydroxylation, carbonyl reduction, fluoride substitution, epoxide deoxygenation, and Wittig-type couplings.